ExLibris header image
SFX Logo
Title: Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association
Source:

Genomics [0888-7543] Yu, Chang-En yr:2007


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Risner, M. "Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease." The pharmacogenomics journal 6.4 (2006): 246-254. Link to Full Text for this item Link to SFX for this item
2. Abraham,, Richard, R. "A genome-wide association study for late-onset Alzheimer's disease using DNA pooling." BMC medical genomics 1.1 (2008): 44-44. Link to Full Text for this item Link to SFX for this item
3. Li, Y. "Evidence that Common Variation in NEDD9 is Associated with Susceptibility to Late-onset Alzheimer's and Parkinson's Disease." Human Molecular Genetics 17.5 (2008): 759-767. Link to SFX for this item
4. Lars, Lars m. "Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE." American journal of human genetics 83.5 (2008): 623-32. Link to Full Text for this item Link to SFX for this item
5. Peskind, Elaine R. "Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial." The American journal of geriatric psychiatry 14.8 (2006): 704-715. Link to SFX for this item
6. DeFelice, L. "Polyspermy prevention: facts and artifacts?" Journal of assisted reproduction and genetics 28.3 (2011): 199-207. Link to Full Text for this item Link to SFX for this item
7. Williams, Julie J. "Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants." Human Molecular Genetics 16.8 (2007): 865-73. Link to SFX for this item
8. Daly, Jeffrey J. "Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease." Nature genetics 40.8 (2008): 955-62. Link to Full Text for this item Link to SFX for this item
9. Boulay, G. "The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells." Cellular signalling 17.4 (2005): 437-45. Link to SFX for this item
10. Wedderburn C, C. "The utility of the Cambridge Behavioural Inventory in neurodegenerative disease." Journal of neurology, neurosurgery and psychiatry 79.5 (2008): 500-503. Link to SFX for this item
11. Serretti, A. "Genetics of Alzheimer's Disease. A Rapidly Evolving Field." Journal of Alzheimer's disease 12.1 (2007): 73-92. Link to SFX for this item
12. Huang, Karl H W. "Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease." Proceedings of the National Academy of Sciences of the United States of America 103.15 (2006): 5644-51. Link to Full Text for this item Link to SFX for this item
13. Frey, A. "Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease." Journal of neural transmission 113.11 (1996): 1753-1761. Link to Full Text for this item Link to SFX for this item
14. Watson, G Stennis S. "Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: A preliminary study." The American journal of geriatric psychiatry 13.11 (2005): 950-8. Link to SFX for this item
15. Mahley, R. W. "Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)." The pharmacogenomics journal 7.1 (2007): 10-28. Link to Full Text for this item Link to SFX for this item
16. Porsteinsson, A. "Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial." Current Alzheimer research 5.1 (2008): 83-9. Link to SFX for this item
17. van Dyck, E H. "A 24-week Randomized, Controlled Trial of Memantine in Patients With Moderate-to-severe Alzheimer Disease." Alzheimer disease and associated disorders 21.2 (2007): 136-143. Link to SFX for this item
18. Carrasquillo, M. "Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease." Nature genetics 41.2 (2009): 192-198. Link to Full Text for this item Link to SFX for this item
19. Reisberg, B. "Memantine in moderate-to-severe Alzheimer's disease." The New England journal of medicine 349.6 (2003): 1333-41. Link to SFX for this item
20. Seshadri, S. "Genome-wide analysis of genetic loci associated with Alzheimer disease." JAMA 303.18 (2010): 1832-1840. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.